CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Table 4 (Details) - USD ($)
$ in Thousands |
12 Months Ended |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
$ 524,937
|
$ 518,523
|
$ 485,219
|
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(324,808)
|
(356,965)
|
(343,320)
|
| Change in accounts payable related to capital expenditures |
(3,156)
|
4,903
|
(5,384)
|
| Acquisitions |
(142,500)
|
0
|
0
|
| Increase in other long-term assets |
(3,564)
|
0
|
0
|
| Proceeds from sale or disposition of assets |
17,132
|
26,012
|
119,006
|
| Proceeds from insurance recoveries |
4,867
|
0
|
0
|
| Increase in note receivable from Axeon |
0
|
(13,328)
|
(80,961)
|
| Investment in subsidiaries |
|
0
|
0
|
| Other, net |
0
|
(853)
|
(302)
|
| Net cash used in investing activities |
(452,029)
|
(340,231)
|
(310,961)
|
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
1,683,631
|
1,318,619
|
1,738,451
|
| Debt repayments |
(1,316,910)
|
(1,121,670)
|
(2,150,743)
|
| Proceeds from note offering, net of issuance costs |
0
|
0
|
686,863
|
| Distributions to unitholders and general partner |
(392,204)
|
(392,204)
|
(392,204)
|
| (Payments for) proceeds from termination of interest rate swaps |
0
|
0
|
(33,697)
|
| Contributions from (distributions to) affiliates |
|
0
|
0
|
| Net intercompany activity |
0
|
0
|
0
|
| Other, net |
(3,746)
|
7,070
|
1,980
|
| Net cash used in financing activities |
(29,229)
|
(188,185)
|
(149,350)
|
| Effect of foreign exchange rate changes on cash |
(12,729)
|
(2,938)
|
(7,767)
|
| Net increase (decrease) in cash and cash equivalents |
30,950
|
(12,831)
|
17,141
|
| Cash and cash equivalents as of the beginning of the period |
87,912
|
100,743
|
83,602
|
| Cash and cash equivalents as of the end of the period |
118,862
|
87,912
|
100,743
|
| Eliminations |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
(588,326)
|
(539,309)
|
(392,243)
|
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
0
|
0
|
0
|
| Change in accounts payable related to capital expenditures |
0
|
0
|
0
|
| Proceeds from sale or disposition of assets |
0
|
0
|
0
|
| Proceeds from insurance recoveries |
0
|
|
|
| Increase in note receivable from Axeon |
|
0
|
0
|
| Investment in subsidiaries |
|
(13,317)
|
(228)
|
| Other, net |
|
0
|
0
|
| Net cash used in investing activities |
0
|
(13,317)
|
(228)
|
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
0
|
0
|
0
|
| Debt repayments |
0
|
0
|
0
|
| Proceeds from note offering, net of issuance costs |
|
|
0
|
| Distributions to unitholders and general partner |
588,326
|
539,309
|
392,243
|
| (Payments for) proceeds from termination of interest rate swaps |
|
|
0
|
| Contributions from (distributions to) affiliates |
|
13,340
|
228
|
| Net intercompany activity |
0
|
0
|
0
|
| Other, net |
0
|
(23)
|
0
|
| Net cash used in financing activities |
588,326
|
552,626
|
392,471
|
| Effect of foreign exchange rate changes on cash |
0
|
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
0
|
0
|
0
|
| Cash and cash equivalents as of the beginning of the period |
0
|
0
|
0
|
| Cash and cash equivalents as of the end of the period |
0
|
0
|
0
|
| NuStar Energy |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
389,967
|
390,543
|
390,002
|
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
0
|
0
|
0
|
| Change in accounts payable related to capital expenditures |
0
|
0
|
0
|
| Acquisitions |
0
|
|
|
| Increase in other long-term assets |
0
|
|
|
| Proceeds from sale or disposition of assets |
0
|
0
|
0
|
| Proceeds from insurance recoveries |
0
|
|
|
| Increase in note receivable from Axeon |
|
0
|
0
|
| Investment in subsidiaries |
|
(23)
|
(302)
|
| Other, net |
|
23
|
302
|
| Net cash used in investing activities |
0
|
0
|
0
|
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
0
|
0
|
0
|
| Debt repayments |
0
|
0
|
0
|
| Proceeds from note offering, net of issuance costs |
|
|
0
|
| Distributions to unitholders and general partner |
(392,204)
|
(392,204)
|
(392,204)
|
| (Payments for) proceeds from termination of interest rate swaps |
|
|
0
|
| Contributions from (distributions to) affiliates |
|
0
|
0
|
| Net intercompany activity |
2,199
|
1,680
|
(3,880)
|
| Other, net |
0
|
0
|
(47)
|
| Net cash used in financing activities |
(390,005)
|
(390,524)
|
(396,131)
|
| Effect of foreign exchange rate changes on cash |
0
|
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
(38)
|
19
|
(6,129)
|
| Cash and cash equivalents as of the beginning of the period |
923
|
904
|
7,033
|
| Cash and cash equivalents as of the end of the period |
885
|
923
|
904
|
| NuStar Logistics |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
237,780
|
221,422
|
210,742
|
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(201,388)
|
(273,785)
|
(224,798)
|
| Change in accounts payable related to capital expenditures |
(4,950)
|
8,741
|
(9,700)
|
| Acquisitions |
0
|
|
|
| Increase in other long-term assets |
0
|
|
|
| Proceeds from sale or disposition of assets |
10,320
|
651
|
118,806
|
| Proceeds from insurance recoveries |
0
|
|
|
| Increase in note receivable from Axeon |
|
(13,328)
|
(80,961)
|
| Investment in subsidiaries |
|
0
|
527
|
| Other, net |
|
(45)
|
(604)
|
| Net cash used in investing activities |
(196,018)
|
(277,766)
|
(196,730)
|
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
1,589,131
|
1,318,619
|
1,738,451
|
| Debt repayments |
(1,275,910)
|
(1,121,670)
|
(1,866,282)
|
| Proceeds from note offering, net of issuance costs |
|
|
686,863
|
| Distributions to unitholders and general partner |
(196,102)
|
(245,127)
|
(392,204)
|
| (Payments for) proceeds from termination of interest rate swaps |
|
|
(33,697)
|
| Contributions from (distributions to) affiliates |
|
0
|
302
|
| Net intercompany activity |
(155,278)
|
83,387
|
(128,277)
|
| Other, net |
(3,605)
|
(1,166)
|
2,027
|
| Net cash used in financing activities |
(41,764)
|
34,043
|
7,183
|
| Effect of foreign exchange rate changes on cash |
0
|
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
(2)
|
(22,301)
|
21,195
|
| Cash and cash equivalents as of the beginning of the period |
6
|
22,307
|
1,112
|
| Cash and cash equivalents as of the end of the period |
4
|
6
|
22,307
|
| NuPOP |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
119,928
|
111,931
|
84,490
|
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(39,533)
|
(14,625)
|
(19,049)
|
| Change in accounts payable related to capital expenditures |
33
|
789
|
824
|
| Acquisitions |
0
|
|
|
| Increase in other long-term assets |
0
|
|
|
| Proceeds from sale or disposition of assets |
22
|
22
|
35
|
| Proceeds from insurance recoveries |
0
|
|
|
| Increase in note receivable from Axeon |
|
0
|
0
|
| Investment in subsidiaries |
|
13,340
|
0
|
| Other, net |
|
0
|
0
|
| Net cash used in investing activities |
(39,478)
|
(474)
|
(18,190)
|
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
0
|
0
|
0
|
| Debt repayments |
0
|
0
|
(250,000)
|
| Proceeds from note offering, net of issuance costs |
|
|
0
|
| Distributions to unitholders and general partner |
(196,102)
|
(147,077)
|
0
|
| (Payments for) proceeds from termination of interest rate swaps |
|
|
0
|
| Contributions from (distributions to) affiliates |
|
0
|
0
|
| Net intercompany activity |
115,652
|
35,620
|
183,700
|
| Other, net |
0
|
0
|
0
|
| Net cash used in financing activities |
(80,450)
|
(111,457)
|
(66,300)
|
| Effect of foreign exchange rate changes on cash |
0
|
0
|
0
|
| Net increase (decrease) in cash and cash equivalents |
0
|
0
|
0
|
| Cash and cash equivalents as of the beginning of the period |
0
|
0
|
0
|
| Cash and cash equivalents as of the end of the period |
0
|
0
|
0
|
| Non-Guarantor Subsidiaries |
|
|
|
| Cash flows from operating activities: |
|
|
|
| Net cash provided by (used in) operating activities |
365,588
|
333,936
|
192,228
|
| Cash flows from investing activities: |
|
|
|
| Capital expenditures |
(83,887)
|
(68,555)
|
(99,473)
|
| Change in accounts payable related to capital expenditures |
1,761
|
(4,627)
|
3,492
|
| Acquisitions |
(142,500)
|
|
|
| Increase in other long-term assets |
(3,564)
|
|
|
| Proceeds from sale or disposition of assets |
6,790
|
25,339
|
165
|
| Proceeds from insurance recoveries |
4,867
|
|
|
| Increase in note receivable from Axeon |
|
0
|
0
|
| Investment in subsidiaries |
|
0
|
3
|
| Other, net |
|
(831)
|
0
|
| Net cash used in investing activities |
(216,533)
|
(48,674)
|
(95,813)
|
| Cash flows from financing activities: |
|
|
|
| Debt borrowings |
94,500
|
0
|
0
|
| Debt repayments |
(41,000)
|
0
|
(34,461)
|
| Proceeds from note offering, net of issuance costs |
|
|
0
|
| Distributions to unitholders and general partner |
(196,122)
|
(147,105)
|
(39)
|
| (Payments for) proceeds from termination of interest rate swaps |
|
|
0
|
| Contributions from (distributions to) affiliates |
|
(13,340)
|
(530)
|
| Net intercompany activity |
37,427
|
(120,687)
|
(51,543)
|
| Other, net |
(141)
|
8,259
|
0
|
| Net cash used in financing activities |
(105,336)
|
(272,873)
|
(86,573)
|
| Effect of foreign exchange rate changes on cash |
(12,729)
|
(2,938)
|
(7,767)
|
| Net increase (decrease) in cash and cash equivalents |
30,990
|
9,451
|
2,075
|
| Cash and cash equivalents as of the beginning of the period |
86,983
|
77,532
|
75,457
|
| Cash and cash equivalents as of the end of the period |
117,973
|
$ 86,983
|
$ 77,532
|
| Eliminations |
|
|
|
| Cash flows from investing activities: |
|
|
|
| Acquisitions |
0
|
|
|
| Increase in other long-term assets |
$ 0
|
|
|